Kaposi sarcoma, primary site (Q38838): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Neoplasia maligna caracterizada por uma proliferação vascular que geralmente contém células endoteliais. Extravasamento de eritrócitos e deposição de hemossiderina estão frequentemente presentes. O local de envolvimento mais frequente é a pele; no entanto, também pode ocorrer internamente. Geralmente se desenvolve em pessoas com sistema imunológico comprometido, incluindo aqueles com síndrome da imunodeficiência adquirida (AIDS). | |||
| description / en | description / en | ||
A malignant neoplasm characterised by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS). | |||
Revision as of 04:04, 13 August 2026
A malignant neoplasm characterised by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2B57 |
||
| English | Kaposi sarcoma, primary site |
A malignant neoplasm characterised by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS). |
